Exclusive with CELLINK Co-Founders Erik Gatenholm and Dr. Héctor Martínez in Medgadget

CELLINK is a 3D bioprinting company based in Gothenburg, Sweden, and was one of the first companies in the world to offer 3D printable bioink, which is used to print human organs and tissues. In just four years of existence, the company has been able to commercialize products used in more than 700 labs and 50 countries. This startup has made a lot of important strides in creating the technology essential to making 3D bioprinting more widespread and accessible to those without the necessary resources. In addition, Cellink has taken a multidisciplinary, tactical approach to conquering tissue bioengineering by looking at the problem bottom-up as well as top-down – from genetics, proteomics, extracellular matrix constituents, and adhesion molecules to scaffold structure, high-fidelity 3D models, and high-level bioengineering.

Having helped create the first 3D bioprinted cornea, CELLINK has also recently come out with the first holographic bioprinter called Holograph X. In 2017, CELLINK’s IPO was more than 1070% over-subscribed and the founder Erik Gatenholm was also placed on the Forbes’ “30 under 30” list in 2018. The company’s acquisition of Dispendix GmbH at the end of 2018 promises exciting additions to their innovations.

I had the opportunity to talk to the co-founders about CELLINK’s journey and technology at the Science in the Age of Experience conference hosted by Dassault Systèmes.

Read Article Here.

More News